Five pharma companies fine-tune OpenFold3 federatively, lifting ligand-pose accuracy from 29% to 47%
AllThingsApx · x · 2026-09-14
Five pharma companies fine-tuned OpenFold3 in a federated setting on 20,000+ structures, raising correct ligand-pose predictions from 29% to 47%. The work builds on the OpenFold consortium, now backed by nearly 50 companies, and is reproducible thanks to open-source AI and Muhammad AlQuraishi's lab.
More from Companies & People
- Palantir tops founder talent-density ranking, beating Stanford; CEO Karp touts 'Palantir degree' — BrettKrieger12 · 2026-10-31
- Indian dev on LLM race: 'We can't outspend Chinese labs,' even sub-100B models win — PrasoonPratham · 2026-10-31
- Dev slams Copilot but praises GitHub execs after candid Universe chats — DanWahlin · 2026-10-31
- Sequoia's Maguire pushes back on Ed Zitron's OpenAI jab: "People have no idea what's coming" — shaunmmaguire · 2026-10-31
- Stratechery insight: Palantir's FDE is a product strategy, not just a role — annetgriffin · 2026-10-31
- Google's Web AI Summit 2026 draws 1K+ RSVPs with 24 speakers, 25 edge-AI demos — jason_mayes · 2026-10-31